- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SonoSite posts $10 million in sales for 1999
Portable ultrasound vendor SonoSite topped the $10 million mark in revenues in its first year since being spun off by ATL. Not surprisingly, the bulk of those revenues came in the fourth quarter (end-December), following launch of the Bothell, WA-based
Portable ultrasound vendor SonoSite topped the $10 million mark in revenues in its first year since being spun off by ATL. Not surprisingly, the bulk of those revenues came in the fourth quarter (end-December), following launch of the Bothell, WA-based companys first two commercial product platforms, the SonoSite 180 hand-held ultrasound system and the SonoHeart hand-held echocardiography system (SCAN 9/29/99 and 1/12/00). SonoSite began shipping SonoHeart this month.
Despite revenues of $9.4 million for the fourth quarter and $10.1 million for the year, SonoSite still reported hefty losses at years end: Losses for the year were $21.6 million, compared to $13 million for 1998. This was due in part to increases in operating expenses related to product and personnel ramp-up in support of the companys new product lines. Fourth-quarter losses reflect the companys new revenue streams, however; losses for the quarter were $3.2 million, compared to losses of $4.7 million for the fourth quarter of 1998.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
